E478 is a novel and proprietary small molecule that uses AHR antagonism to expand gene-modified
hematopoietic stem cells during manufacture, then the corrected cells are infused as the medicine for the patient.
Presentation: A Novel Aryl Hydrocarbon Receptor Antagonist Expands Adult Human
Hematopoietic Stem Cells from Mobilized Peripheral Blood and Bone Marrow and Increases the Dose of CRISPR/Cas9 Gene-Edited NSG-Repopulating Cells, Abstract #979
Omeros Corporation announced the recent presentation of a case report describing resolution of gastrointestinal
hematopoietic stem cell transplant-associated thrombotic microangiopathy following narsoplimab treatment under a compassionate-use protocol.
[USPRwire, Thu Dec 27 2018] A new report titled " Global
Hematopoietic Stem Cell Transplantation Market Industry Assessment & Growth Forecast Examined During 2024 " has been included in the enormous research repository of Market Research Reports Search Engine (MRRSE) that compiles various facets of the
Hematopoietic Stem Cell Transplantation Market at a global level portraying a holistic analysis of the marketplace along with intelligence on key participants.
An anti-CD117 ADC conjugated with amanitin potently depleted human and non-human primate
hematopoietic stem cells and progenitors in vivo.
This NMPA's approval for Melphalan Hydrochloride For Injection (EVOMELA) is indicated as a high-dose conditioning treatment prior to
hematopoietic progenitor (stem) cell transplantation in patients with multiple myeloma and the palliative treatment of patients with multiple myeloma for whom oral therapy is not appropriate.
BEIJING -- A Pakistan citizen to have received umbilical cord blood in China as part of a
hematopoietic stem cell transplant was discharged from hospital.
Because of the critical shortage of blood cells in clinical settings, several strategies have been established to generate
hematopoietic stem cells (HSCs) and mature blood cells from hPSCs (10,11).
Islamabad -- A 30-year-old Pakistani man successfully received transplantation of cord blood
hematopoietic stem cells provided by China Stem Cell Group at Shanghai General Hospital's Southern Division in Songjiang district, Chinese media reported on Thursday, says a message received here from Beijing.
MYELOABLATIVE autologous
hematopoietic stem-cell transplantation shows long-term benefits for patients with severe scleroderma, with improved event-free and overall survival over intravenous cyclophosphamide, according to Keith M.
In contrast, in severe myelosuppressive states such as aplastic anemia or after irradiation, when
hematopoietic tissues are damaged, adipocytes expand their lipid contents, indicating that a fatty change occurs in the BM [1].